Alpa Laboratories Ltd.
Snapshot View

63.50 -2.45 ▼-3.7%

12 August 2022, 04:01:00 PM
Volume: 6,371

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alpalabs.in
Market Cap 133.61 Cr.
Enterprise Value(EV) 136.95 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 6.70 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 9.48 Trailing Twelve Months Ending 2022-03
Industry PE 32.02 Trailing Twelve Months Ending 2022-03
Book Value / Share 57.86 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.10 Calculated using Price: 63.50
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 2.10 Cr. 21,040,600 Shares
FaceValue 10
Company Profile
Alpa Laboratories, incorporated in 1988, is engaged in the business of manufacturing pharmaceutical products. In 1967, the company started its journey as a partnership concern with Purushottam R Patel, M S Chawla and Pravin C Shah as the founding partners. Later on March 18, 1988 the company became a private limited company and a decade later it became a public limited enterprise.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.71%
1 Week
-3.57%
1 Month
+4.79%
3 Month
-1.47%
6 Month
-21.51%
1 Year
+17.27%
2 Year
+152.49%
5 Year
+123.99%
10 Year
+683.95%
8 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -5.84 -1.60 7.61 2.68 2.92 1.03 1.86 6.97
Return on Capital Employed (%) -2.54 -0.89 9.61 6.59 5.47 3.26 3.09 10.42
Return on Assets (%) -4.07 -1.10 4.99 1.86 2.29 0.84 1.54 5.56

Balance Sheet View Details >>

Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 88 87 93 95 98 98 100 108 122
Non Curr. Liab. 6 0 1 0 0 0 -1 0 2
Curr. Liab. 32 41 52 30 23 22 21 33 31
Minority Int.
Equity & Liab. 127 128 146 125 121 121 120 140 155
Non Curr. Assets 74 16 27 20 23 27 25 19 16
Curr. Assets 53 113 119 105 98 94 95 121 139
Misc. Exp. not W/O
Total Assets 127 128 146 125 121 121 120 140 155

Profit Loss View Details >>

Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 57 57 54 63 63 78 86 98 112
Other Income 1 3 6 5 5 5 3 4 11
Total Income 57 61 59 69 68 83 89 102 123
Total Expenditure -51 -55 -47 -56 -59 -77 -83 -90 -102
PBIDT 6 6 12 12 9 6 6 12 21
Interest -2 -2 -1 -2 -1 -1 0 0 0
Depreciation -9 -6 -1 -3 -3 -3 -3 -1 -2
Taxation 0 1 -3 -3 -2 -2 -1 -4 -5
Exceptional Items -1 -2
PAT -5 -1 7 3 3 1 2 7 14
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -5 -1 7 3 3 1 2 7 14
Adjusted EPS -2 -1 3 1 1 0 1 3 7

Cash Flow View Details >>

Particulars 8 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 8 -2 -22 17 -13 -1 18 -2
Cash Fr. Inv. -2 37 -8 -2 -11 -15 -11 6
Cash Fr. Finan. 4 7 -6 -15 9 -5 -1 0
Net Change 10 42 -36 0 -15 -20 5 4
Cash & Cash Eqvt 10 53 17 37 21 1 6 11

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 56.66 56.66 56.66 56.66 56.66 56.66 56.66 57.29 57.29
Public 43.34 43.34 43.34 43.34 43.34 43.34 43.34 42.71 42.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 13 Aug 2022
Financial Results For The Quarter Ended 30 June 2022.
Alpa Laboratories Limited has submitted the financial results quarter ended 30 June 2022.
Tue, 02 Aug 2022
Board Meeting Intimation for Quarterly Results For The Period Ended June 30 2022
ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 inter alia to consider and approve The quarterly results for the period ended June 30 2022 and other business matters
Mon, 04 Jul 2022
Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- SWATI BAGH
Designation :- Company Secretary and Compliance Officer

Technical Scans View Details >>

Fri, 12 Aug 2022
High Delivery Percentage High Delivery Percentage
High Decrease 6 Months High Decrease 6 Months
High Increase 2 Years High Increase 2 Years
High Increase 5 Years High Increase 5 Years
Closing Near 20 SMA Closing Near 20 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Divi's Laboratories Ltd. 98,918.90 3,726.20 -5.6%
Cipla Ltd. 82,906.37 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 33.32 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 3.86 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%

FAQ's On Alpa Laboratories Ltd.

Can I Buy Alpa Lab Shares now?

What is the Share Price of Alpa Lab?

What is the Relative Strength Index (RSI) Value of Alpa Lab?

What is the Market Capital (MCAP) of Alpa Lab?

What are the key metrics to analyse Alpa Lab?

What is the Price Performance of Alpa Lab?